Moderna recently reported the results from a phase 3 trial of its two-in-one COVID and flu vaccine.
Academic rigour, journalistic flair
Articles on Immunisation
Displaying 1 - 20 of 93 articles
Vaccinating public village leaders or respected older community members might be an effective approach to increasing vaccine uptake.
At the moment, a child’s access to certain shots can differ depending on whether they live in Queensland or Tasmania.
The RSV shot children in WA will get is a monoclonal antibody. Here’s what that means.
We tend to just think of viruses in terms of their damaging impacts on human health and lives. But viruses can also be used to benefit human health, agriculture and the environment.
Nigeria’s medical community is mourning the death of public health physician and university administrator, Emeritus Professor Umaru Shehu.
Millions of high-risk older Australians aren’t getting recommended vaccinations against COVID, the flu, pneumococcal disease and shingles.
Getting vaccinated is the best way to protect against diphtheria.
Cases of the flu and COVID are set to rise over winter, with many people looking to get vaccinated against both viruses.
As people flock back to offices and pack public transport, we’re seeing more cases of the flu than in recent years. The flu shot isn’t perfect but it cuts your chance of being hospitalised.
Tetanus is a rare but potentially fatal disease. Being up to date with tetanus vaccination is your best protection.
The pandemic has disrupted national immunisation programmes. As a result, the African continent is seeing more outbreaks of vaccine preventable diseases.
The risk of serious disease outbreaks among NZ children is now very real. Some childhood immunisation rates have dropped from about 80% in early 2020 to 67% by June 2022, and as low as 45% for Māori.
Emerging evidence shows the COVID pandemic has seen fewer people receiving routine medical care across many areas. Here’s what we know about the impact that’s having – and could have down the track.
Parents can now choose Moderna to vaccinate their children against COVID. So how effective is it, and how does it compare with Pfizer?
The Pfizer COVID-19 vaccine will be available for children aged 5-11 from January 10, after it cleared the final regulatory step. Here’s what you need to know.
Australia’s regulator has approved the Pfizer COVID vaccine for 5-11 year olds, with the rollout expected to start on January 10. Here’s how to prepare your child if they’re fearful of needles.
Many countries, including South Africa, use regulations to control smoking in public so that they do not harm non-smokers. Likewise, getting vaccinated is for the common good of society.
The international evidence so far shows COVID vaccines are safe for pregnant women and effective at preventing severe disease.
Vaccinating a population requires a proactive approach to health promotion and community preparedness.
Top contributors
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor, Susan Wakil School of Nursing and Midwifery, University of Sydney
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Paediatrician, Infectious Diseases Physician and Clinical Microbiologist, Telethon Kids Institute, The University of Western Australia
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Fellow, Nigerian Academy of Science
-
Associate Principal Research Fellow, Burnet Institute
-
Honorary Research Fellow, Macquarie University
-
Associate Professor, University of Sydney
-
Adjunct Professor, Macquarie University
-
Paediatrician, National Centre for Immunisation Research and Surveillance; Clinical Lecturer, Children's Hospital Westmead Clinical School, University of Sydney
-
Associate Professor, School of Public Health, Global Disease Epidemiology and Control, Johns Hopkins University
-
Professor of Infectious Diseases, Monash University
